BLFS - CIK 0000834365
The table below shows BIOLIFE SOLUTIONS INC's cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Operating cash flow | $20.11M | $8.43M | -$12.50M | -$8.49M | -$4.59M | $6.64M |
| Capital expenditure | $9.48M | $3.23M | $6.38M | $10.38M | $8.38M | $1.96M |
| Investing cash flow | -$71.54M | $58.30M | $17.84M | -$58.12M | -$13.19M | -$24.71M |
| Dividends paid | - | - | - | - | - |
BIOLIFE SOLUTIONS INC reported operating cash flow of $20.11M for fiscal year 2025. That is up 138.6% from $8.43M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow grew from -$4.33M (FY 2016) to $20.11M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| - |
| Stock buybacks | - | - | - | - | - | - |
| Financing cash flow | -$10.92M | -$6.78M | $10.59M | $16.32M | -$2.78M | $102.08M |